The Narcotics Control Bureau (NCB) has busted an alleged inter-state network involved in the illegal supply of controlled and restricted pharmaceutical drugs from Delhi to Jammu and Kashmir. Four people have been arrested so far, while investigators have seized more than five lakh tablets, capsules and bottles of pharmaceutical medicines, along with over seven kilograms of codeine-based cough syrup.
The seized medicines include Tramadol Hydrochloride, Alprazolam, Nitrazepam and codeine-containing pharmaceutical products. The recovery was made during coordinated operations by the NCB’s Jammu and Delhi zonal units, which were aimed at identifying how controlled medicines were allegedly being diverted from the legitimate pharmaceutical supply chain and distributed through illegal channels.
How the NCB Traced the Drug Supply Network
According to the agency, it had received intelligence inputs about large consignments of pharmaceutical drugs being transported from Delhi to different parts of Jammu and Kashmir. Following the information, the NCB began monitoring suspected supply routes and individuals believed to be connected with the operation.
The investigation led to an operation on the morning of November 16, 2026, when the NCB’s Jammu unit intercepted a passenger bus travelling towards Srinagar near the Mada Toll Plaza in Chenani, Udhampur district.
During the search, officials allegedly recovered around seven kilograms of codeine-based cough syrup from a passenger identified as a resident of Bhaderwah in Doda district. Following the seizure, the agency registered a case under the Narcotic Drugs and Psychotropic Substances (NDPS) Act and launched a detailed investigation.
The NCB subsequently expanded its investigation into the Kashmir Valley and identified the alleged key recipient of the cough syrup consignment, who was reportedly a resident of Anantnag. Investigators then began examining the links connecting the recipient to suppliers and distributors operating in Delhi.
Raids in Delhi Lead to Four Arrests
Based on the leads developed during the investigation, the NCB’s Jammu and Delhi units coordinated their operations in the national capital. On November 18, officials conducted searches at locations linked to the suspected supply network and arrested individuals allegedly involved in the operation.
During the action, 356 bottles of codeine-based cough syrup were also seized. Investigators suspected that the network had established arrangements in Delhi for storing pharmaceutical products and distributing them to different destinations.
Further investigation led the agency to a suspected secret warehouse operating from a rented premises in the Shahdara area of Delhi. The facility was allegedly being used to store large quantities of pharmaceutical medicines.
Searches conducted on November 18 and 19 resulted in the recovery of more than five lakh tablets, capsules and medicine bottles. The seized stock included Tramadol Hydrochloride, Alprazolam, Nitrazepam and codeine-based pharmaceutical products.
The agency has arrested four people in connection with the case so far. Their alleged roles and the extent of their involvement are being examined as the investigation progresses.
FCRF Launches Certified Chief Risk Officer (CRO) Program for India’s Risk Leaders
Investigation Focuses on Suppliers, Distributors and Financial Links
The medicines recovered during the operation are used for legitimate medical purposes. However, their unauthorised storage, distribution and misuse can contribute to illegal drug trafficking. Tramadol and codeine-based products, in particular, are subject to regulatory controls because of the risk of misuse and dependence. Alprazolam and Nitrazepam are also controlled medicines.
The NCB is now investigating how such a large quantity of medicines was procured and whether the products were diverted from authorised pharmaceutical channels. Officials are examining purchase and sales records, transportation arrangements, supply documents and the individuals allegedly involved in moving the consignments.
The investigation is not limited to the arrests and seizures. The agency is attempting to identify the alleged suppliers who arranged the medicines, distributors who transported them towards the Kashmir Valley and other possible destinations, and individuals who may have provided financial support to the operation.
Investigators are also examining financial transactions and the movement of funds to establish how the alleged illegal business was organised and operated. The agency is analysing documents recovered during searches and questioning the arrested accused to identify further links in the network.
The NCB’s next phase of investigation will focus on tracing the wider supply chain, identifying additional suspects and determining how controlled pharmaceutical products were allegedly removed from the legitimate market and channelled into illegal distribution networks.
The operation has exposed suspected links between drug storage facilities in Delhi and the supply of controlled medicines to Jammu and Kashmir. Further investigation is expected to establish the full extent of the network and the number of people allegedly involved.
